Skip to main content

Vincerx Pharma, Inc.

VINCDelisted Apr 28, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001796129

Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Vincerx Pharma, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of VINC: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5655−1
Shares12.1M15.4M+3.32M (+27.4%)
Value$157.3M$248.9M+$91.6M (+58.2%)

New holders (8)

Institutions that held Vincerx Pharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to VINC in Q3 2021
InstitutionSharesValue% of portfolio
Deerfield Management Company, L.P. (Series C)1,379,310$22.3M0.44%
Rock Springs Capital Management LP800,295$12.9M0.27%
Point72 Asset Management, L.P.344,827$5.14M0.02%
Baker Bros. Advisors LP241,379$3.90M0.02%
Hudson Bay Capital Management LP200,000$3.00M0.04%
Nuveen Asset Management, LLC72,342$1.14M0.00%
Cubist Systematic Strategies, LLC1,535$25.0K0.00%
TCI Wealth Advisors, Inc.60$1.00K0.00%

Sold out (9)

Institutions that held Vincerx Pharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of VINC in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Bank of Montreal252,902$3.18M
Putnam Investments LLC221,035$2.87M
J. Goldman & Co LP116,160$1.51M
Millennium Management LLC51,043$663.0K
Creative Planning35,000$455.0K
Murchinson Ltd.29,037$377.0K
Jump Financial, LLC20,000$260.0K
Shay Capital LLC11,361$148.0K
Penserra Capital Management LLC3,312$43.0K